CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
about
Evaluation of the clinical effectiveness of bioactive glass (S53P4) in the treatment of non-unions of the tibia and femur: study protocol of a randomized controlled non-inferiority trial.A Preliminary Study of Contrast-Enhanced Ultrasound (CEUS) and Cytokine Expression Analysis (CEA) as Early Predictors for the Outcome of Tibial Non-Union Therapy
P2860
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@ast
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@en
type
label
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@ast
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@en
prefLabel
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@ast
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@en
P2093
P2860
P356
P1433
P1476
CCL-2 as a possible early marker for remission after traumatic spinal cord injury.
@en
P2093
A Moghaddam
G Schmidmaier
K Kunzmann
P A Grützner
P Haubruck
P2860
P2888
P304
P356
10.1038/SC.2017.69
P50
P577
2017-06-20T00:00:00Z